Asylia Diagnostics - precision medicine data platform for immunotherapies
Asylia Diagnostics has raised $1.1M in total funding. The most recent round was Seed. The last funding was announced in July 2021.
Asylia Diagnostics's investors include imec, Davidovs Venture Collective, BlueHealth Innovation Center.
Asylia Diagnostics is headquartered in Delaware City, United States.
Asylia Diagnostics - precision medicine data platform for immunotherapies
Asylia Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Asylia Diagnostics — Funding & Investors." VCBacked, July 12, 2021, https://www.vcbacked.co/company/asylia-diagnostics. Accessed August 15, 2026.
VCBacked. (2021). Asylia Diagnostics — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/asylia-diagnostics
{{cite web |title=Asylia Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/asylia-diagnostics |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated